Table 4 A summary of the meta-analysis for the improvement of neurological impairment

AADN

0.54(0.33, 0.75) I² = 13.4% P = 0.32

–

0.51(− 0.02, 1.03) I² = 79.8% P = 0.007

1.01(0.04, 1.98) I² = 85.2% P = 0.009

–

–

0.64(0.44, 0.84) I² = 87.2% P = 0.000

0.77(0.43, 1.11) I² = 0%

P = 0.60

0.79(0.44,1.14)

–

0.53(0.01, 1.04)

0.83

(0.51, 1.16) I² = 80.4%

P = 0.02

1.03(0.56, 1.50)

0.41(0.15, 0.66)

–

− 0.71 (− 1.28,-0.13)

DH

–

–

–

–

− 1.01 (− 1.40,-0.62)

–

–

–

–

− 0.61

(− 1.02,-0.20)

–

–

–

− 0.83 (− 2.21,0.56)

−0.12 (− 1.58,1.3)

DS

–

–

–

–

–

–

–

–

–

–

0.31 (− 0.20, 0.81)

–

–

− 0.52 (− 1.15,0.1)

0.19 (− 0.64,1.01)

0.31 (− 1.18,1.8)

DSCXQ

–

–

− 0.82 (− 1.27,-0.37)

–

–

–

–

–

–

–

–

–

−0.59 (− 1.26,0.07)

0.12 (− 0.74,0.96)

0.24 (− 1.23,1.69)

−0.07 (− 0.96,0.8)

DZHS

–

–

–

–

0.84 (0.35, 1.33)

–

–

–

0.75 (0.24, 1.26)

–

–

−0.78 (− 2.19,0.63)

−0.07 (− 1.57,1.41)

0.05 (− 1.88,1.97)

−0.26 (− 1.78,1.2)

−0.19 (− 1.68,1.2)

DZXX

–

–

–

0.03 (− 0.49, 0.55)

–

–

–

–

–

–

0.22 (− 0.3,0.73)

0.92 (0.26,1.58)

1.05 (− 0.32,2.4)

0.74 (0.01,1.47)

0.81 (0.05,1.58)

1.00 (− 0.43,2.43)

FFDS

–

0.79 (0.45,1.13) I² = 0% P = 1

0.07 (−0.03, 0.45)

1.15 (0.58, 1.71)

0.95 (0.49, 1.41)

–

1.31 (−0.05,2.66) I² = 95.7% P = 0

2.41 (1.85, 2.97)

0.44 (−0.12, 1.01)

−0.78 (− 1.47,-0.09)

− 0.07 (− 0.97,0.83)

0.05 (− 1.49,1.58)

−0.26 (− 1.19,0.6)

−0.19 (− 1.16,0.7)

0 (− 1.57,1.57)

− 1 (− 1.86,-0.13)

HHHSS

–

–

–

–

–

–

–

–

− 0.67 (− 1.34,0)

0.04 (− 0.8,0.87)

0.16 (− 1.34,1.64)

−0.14 (− 1.03,0.7)

−0.08 (− 0.99,0.8)

0.11 (− 1.41,1.64)

−0.88 (− 1.55,-0.21)

0.11 (− 0.85,1.08)

SX

–

–

–

–

–

–

–

− 0.81 (− 1.44,− 0.18)

-0.1 (− 0.89,0.69)

0.02 (− 1.44,1.47)

−0.29 (− 1.14,0.5)

−0.22 (− 0.99,0.5)

−0.03 (− 1.29,1.23)

−1.03 (− 1.7,-0.36)

−0.03 (− 0.97,0.91)

−0.14 (− 1,0.72)

SXT

–

− 0.20 (− 0.68,0.28)

−0.79 (− 1.19,-0.39)

–

–

–

− 0.6 (− 1.61,0.39)

0.11 (− 0.97,1.16)

0.23 (−1.41,1.85)

−0.08 (− 1.22,1.0)

−0.01 (− 1.16,1.1)

0.18 (− 1.48,1.83)

−0.82 (− 1.76,0.12)

0.18 (−1.05,1.39)

0.06 (− 1.06,1.18)

0.21 (− 0.87,1.28)

XST1

0.24 (− 0.10,0.58)

–

–

–

–

−0.56 (− 1.22,0.09)

0.14 (− 0.59,0.88)

0.27 (− 1.22,1.75)

−0.04 (− 0.92,0.8)

0.03 (− 0.85,0.9)

0.22 (−1.25,1.69)

−0.78 (− 1.44,-0.12)

0.22 (− 0.74,1.17)

0.1 (− 0.77,0.97)

0.25 (− 0.5,1)

0.04 (− 0.88,0.97)

XST2

–

–

–

–

−0.47 (− 1.13,0.19)

0.24 (− 0.61,1.08)

0.36 (−1.09,1.82)

0.05 (− 0.84,0.9)

0.12 (− 0.74,0.9)

0.31 (− 1.16,1.79)

−0.69 (− 1.43,0.07)

0.31 (− 0.65,1.27)

0.2 (− 0.71,1.1)

0.34 (− 0.42,1.1)

0.13 (−1.01,1.28)

0.09 (− 0.78,0.96)

LI

0.96 (0.51, 1.42)

–

–

−1.14 (− 1.74,-0.54)

−0.43 (− 1.19,0.34)

−0.31 (− 1.57,0.94)

−0.61 (− 1.43,0.2)

−0.55 (− 1.3,0.22)

−0.36 (− 1.82,1.12)

−1.35 (− 1.89,-0.81)

−0.36 (− 1.27,0.56)

−0.47 (− 1.28,0.33)

−0.33 (− 1.08,0.42)

−0.53 (− 1.59,0.52)

−0.57 (− 1.36,0.21)

−0.67 (− 1.42,0.08)

YXDM

–

0.51 (0.06,0.95)

−1.25 (− 2.14,-0.37)

− 0.54 (− 1.56,0.47)

−0.41 (− 2.01,1.18)

−0.72 (− 1.79,0.3)

−0.65 (− 1.73,0.4)

−0.46 (− 2.09,1.17)

− 1.46 (− 2.36,-0.58)

−0.47 (− 1.6,0.65)

−0.58 (− 1.63,0.48)

−0.43 (− 1.48,0.59)

−0.64 (− 1.9,0.62)

−0.68 (− 1.73,0.36)

−0.77 (− 1.86,0.29)

−0.11 (− 1.1,0.88)

SXN

–

− 0.44 (− 1.45,0.57)

0.27 (− 0.84,1.37)

0.39 (− 1.16,1.94)

0.09 (− 1.06,1.2)

0.16 (− 0.98,1.2)

0.35 (− 1.32,2.02)

−0.65 (− 1.58,0.27)

0.34 (− 0.89,1.57)

0.23 (− 0.9,1.36)

0.37 (− 0.73,1.48)

0.17 (− 1.14,1.48)

0.13 (− 0.99,1.24)

0.03 (− 1.1,1.17)

0.7 (− 0.22,1.62)

0.81 (− 0.45,2.08)

MLN